198 related articles for article (PubMed ID: 24202663)
1. Treating heart failure with preserved ejection fraction: statins could make the difference.
Athyros VG; Katsiki N; Karagiannis A
Angiology; 2014 Apr; 65(4):328-9. PubMed ID: 24202663
[No Abstract] [Full Text] [Related]
2. Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction.
Liu G; Zheng XX; Xu YL; Ru J; Hui RT; Huang XH
Am J Cardiol; 2014 Apr; 113(7):1198-204. PubMed ID: 24513478
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy in patients with heart failure and preserved left ventricular function.
Roik M
Circ J; 2009 Jul; 73(7):1359; author reply 1360. PubMed ID: 19556702
[No Abstract] [Full Text] [Related]
4. Statins in heart failure--With preserved and reduced ejection fraction. An update.
Tousoulis D; Oikonomou E; Siasos G; Stefanadis C
Pharmacol Ther; 2014 Jan; 141(1):79-91. PubMed ID: 24022031
[TBL] [Abstract][Full Text] [Related]
5. Treating diastolic heart failure with statins: "phat" chance for pleiotropic benefits.
Zile MR
Circulation; 2005 Jul; 112(3):300-3. PubMed ID: 16027268
[No Abstract] [Full Text] [Related]
6. Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.
Tsujimoto T; Kajio H
Int J Cardiol; 2018 Mar; 255():111-117. PubMed ID: 29307549
[TBL] [Abstract][Full Text] [Related]
7. Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives.
Ovchinnikov A; Potekhina A; Arefieva T; Filatova A; Ageev F; Belyavskiy E
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732177
[TBL] [Abstract][Full Text] [Related]
8. Should chronic heart failure patients with reduced left-ventricular ejection fraction receive angiotensin-receptor blockers?
Pitt B
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):70-1. PubMed ID: 16265371
[No Abstract] [Full Text] [Related]
9. CORONA, statins, and heart failure: who lost the crown?
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
[No Abstract] [Full Text] [Related]
10. Observational studies of statins in heart failure with preserved systolic function.
Fukuta H; Little WC
Heart Fail Clin; 2008 Apr; 4(2):209-16. PubMed ID: 18433701
[TBL] [Abstract][Full Text] [Related]
11. Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
Otto CM
Heart; 2018 Mar; 104(5):361-362. PubMed ID: 29440452
[No Abstract] [Full Text] [Related]
12. The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses.
Fukuta H; Goto T; Wakami K; Ohte N
Int J Cardiol; 2016 Jul; 214():301-6. PubMed ID: 27082778
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of statins in the treatment of heart failure.
Ramasubbu K; Mann DL
J Am Coll Cardiol; 2006 Jan; 47(2):342-4. PubMed ID: 16412858
[No Abstract] [Full Text] [Related]
14. Relationship of loop diuretic use with exercise intolerance in heart failure with preserved ejection fraction.
Montero D; Haider T
Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):138-141. PubMed ID: 29319788
[No Abstract] [Full Text] [Related]
15. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
16. Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.
Figtree GA; Rådholm K; Barrett TD; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B
Circulation; 2019 May; 139(22):2591-2593. PubMed ID: 30882240
[No Abstract] [Full Text] [Related]
17. Beneficial effects of statins in patients with non-ischemic heart failure.
Laufs U; Wassmann S; Schackmann S; Heeschen C; Böhm M; Nickenig G
Z Kardiol; 2004 Feb; 93(2):103-8. PubMed ID: 14963675
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
19. The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction.
Verma S
Cardiovasc Res; 2020 Jan; 116(1):e8-e10. PubMed ID: 31850505
[No Abstract] [Full Text] [Related]
20. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
